# EMERGENCY DEPARTMENT-INITIATED BUPRENORPHINE AND VALIDATION NETWORK TRIAL (CTN-0099). DSC5 CONTRACT. 09/20/2019 - 11/12/2022. N01DA-19-2250.

> **NIH NIH N01** · THE EMMES COMPANY, LLC · 2022 · $490,336

## Abstract

EMERGENCY DEPARTMENT-INITIATED BUPRENORPHINE AND VALIDATION NETWORK TRIAL (CTN-0099).

This study is part of the NIH’s Helping to End Addiction Long-term (HEAL) initiative to speed scientific solutions to the national opioid public health crisis. The NIH HEAL Initiative bolsters research across NIH to improve treatment for opioid misuse and addiction.

## Key facts

- **NIH application ID:** 10701629
- **Project number:** 75N95019D00013-P00001-759501900095-1
- **Recipient organization:** THE EMMES COMPANY, LLC
- **Principal Investigator:** PAUL VANVELDHUISEN
- **Activity code:** N01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2022
- **Award amount:** $490,336
- **Award type:** —
- **Project period:** 2019-09-20 → 2022-11-12

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10701629

## Citation

> US National Institutes of Health, RePORTER application 10701629, EMERGENCY DEPARTMENT-INITIATED BUPRENORPHINE AND VALIDATION NETWORK TRIAL (CTN-0099). DSC5 CONTRACT. 09/20/2019 - 11/12/2022. N01DA-19-2250. (75N95019D00013-P00001-759501900095-1). Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/grant/nih/10701629. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*